Paul Singer’s Elliott Investment Management disclosed in an SEC filing its holdings as of December 31, 2024. The fund exited two positions ...

Fintel reports that on February 5, 2025, Jefferies upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.

Wells Fargo analyst Stephen Baxter maintained Cardinal Health with an Equal-Weight and raised the price target from $135 to ...

Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

Shares of Cardinal Health Inc. CAH advanced 1.82% to $127.45 Wednesday, on what proved to be an all-around great trading ...

Robust demand across its pharmaceutical and specialty solutions segment was the impetus behind Cardinal Health raising its fiscal 2025 enterprise guidance, said Jason Hollar, CEO of Cardinal ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardinal Health (CAH – Research Report) and Apyx ...

Famed activist investor Elliott Investment Management exited its position in Cardinal Health (NYSE:CAH), dumping 2M shares in Q4, according to its 13F filing. The hedge fund increased its stake in ...

One company to watch right now is Cardinal Health (CAH). CAH is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. The stock has a Forward P/E ratio of 15.28. This compares to its ...

Advanced Therapy Connect is a simplified ordering and reporting process for cell and gene therapy products, the company said. Inside Beauty spoke to Jamie Sachs, vice president, product marketing ...

It was the Cardinal’s birthday. The thing is, what do you tell a Cardinal? I know it’s not mazel tov. And what do you give a Cardinal? Forget wardrobe, jeans or a puffer jacket. Can’t go ...